We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

90 hedge funds and large institutions have $80.7M invested in VanEck Biotech ETF in 2019 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 15 increasing their positions, 30 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,239% more call options, than puts

Call options by funds: $6.36M | Put options by funds: $475K

75% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 8

20% more capital invested

Capital invested by funds: $67.4M → $80.7M (+$13.3M)

7% more funds holding

Funds holding: 84 → 90 (+6)

1.77% more ownership

Funds ownership: 17.86% → 19.62% (+1.8%)

50% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 30

Holders
90
Holders Change
+6
Holders Change %
+7.14%
% of All Funds
1.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
15
Reduced
30
Closed
8
Calls
$6.36M
Puts
$475K
Net Calls
+$5.89M
Net Calls Change
+$5.8M

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$3.23M
2
Bank of America
Bank of America
North Carolina
+$1.34M
3
Simplex Trading
Simplex Trading
Illinois
+$885K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$621K
5
MJRIC
Mogy Joel R Investment Counsel
California
+$310K

Top Sellers

Rank Fund Capital Flow
1
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$1.92M
2
Jane Street
Jane Street
New York
-$1.56M
3
VF
Virtu Financial
New York
-$1.53M
4
SFS
Strategic Financial Services
New York
-$1.37M
5
TRCT
Tower Research Capital (TRC)
New York
-$1.27M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
76
Fidelity Investments
Massachusetts
$13K +$12.5K +99 +9,900%
SQA
77
Simon Quick Advisors
New Jersey
$13K +$12.6K +100 New
APA
78
American Portfolios Advisors
New York
$12.8K – – –
JP Morgan Chase
79
JP Morgan Chase
New York
$12K – – –
CAPTRUST Financial Advisors
80
CAPTRUST Financial Advisors
North Carolina
$10K -$2.02K -16 -17%
1NWS
81
1 North Wealth Services
Maryland
$10K – – –
ATC
82
Adirondack Trust Company
New York
$9K – – –
CFA
83
Carroll Financial Associates
North Carolina
$9K +$9.6K +76 New
S
84
SignatureFD
Georgia
$7K +$7.33K +58 New
GRP
85
Global Retirement Partners
California
$6K – – –
CA
86
Cetera Advisors
Colorado
$6K +$6.32K +50 New
BFEC
87
Benjamin F. Edwards & Company
Missouri
$5K – – –
QAM
88
QCI Asset Management
New York
$3K – – –
SWM
89
SeaCrest Wealth Management
New York
$3K – – –
AIP
90
Ameritas Investment Partners
Nebraska
$2K – – –
PA
91
Pinnacle Associates
New York
– -$453K -4,092 Closed
B
92
Bailard
California
– -$233K -2,097 Closed
Deutsche Bank
93
Deutsche Bank
Germany
– -$33K -300 Closed
GCM
94
Gables Capital Management
Florida
– -$17K -150 Closed
FTI
95
Fiduciary Trust International
Massachusetts
– -$5K -45 Closed
GWMIA
96
Global Wealth Management Investment Advisory
Florida
– -$4K -38 Closed
LPWM
97
Lake Point Wealth Management
Texas
– -$2K -19 Closed
DWM
98
Doyle Wealth Management
Florida
– -$2K -15 Closed
1 2 3
4

BBH Hedge Fund Activity: Q1 2019 in Review

90 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q1 2019, worth a combined $80.7M — up 20% from $67.4M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new BBH positions and 8 closed out — a net gain of 6 holders — while 15 added to existing stakes and 30 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $3.23M. The largest seller was Royal Bank of Canada, cutting an estimated $1.92M.

  • 90 institutional investors held VanEck Biotech ETF (BBH) as of Q1 2019, up from 84 in Q4 2018.
  • Funds reported $80.7M of VanEck Biotech ETF stock for Q1 2019, up 20% quarter-over-quarter.
  • 14 funds opened new VanEck Biotech ETF positions in Q1 2019 and 8 closed out, a net change of +6 holders.
  • The largest VanEck Biotech ETF buyer in Q1 2019 was Citadel Advisors, an estimated $3.23M added.
  • The largest VanEck Biotech ETF seller in Q1 2019 was Royal Bank of Canada, an estimated $1.92M sold.

Based on aggregated 13F filings for Q1 2019.